{"id":"https://openalex.org/W2171086149","doi":"https://doi.org/10.1128/aac.01733-09","title":"Cross-Resistance Profile Determination of Two Second-Generation HIV-1 Integrase Inhibitors Using a Panel of Recombinant Viruses Derived from Raltegravir-Treated Clinical Isolates","display_name":"Cross-Resistance Profile Determination of Two Second-Generation HIV-1 Integrase Inhibitors Using a Panel of Recombinant Viruses Derived from Raltegravir-Treated Clinical Isolates","publication_year":2010,"publication_date":"2010-10-19","ids":{"openalex":"https://openalex.org/W2171086149","doi":"https://doi.org/10.1128/aac.01733-09","mag":"2171086149","pmid":"https://pubmed.ncbi.nlm.nih.gov/20956600","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3019647"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01733-09","doi":"https://doi.org/10.1128/aac.01733-09","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01733-09","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3019647","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016308733","display_name":"Liesbeth Van Wesenbeeck","orcid":"https://orcid.org/0000-0002-1760-9854","observed_orcids":["https://orcid.org/0000-0002-1760-9854"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"L. Van Wesenbeeck","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062767419","display_name":"Evelien Rondelez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Rondelez","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079127023","display_name":"Maxim Feyaerts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Feyaerts","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069670202","display_name":"Ann Verheyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Verheyen","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108111797","display_name":"Koen Van der Borght","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Van der Borght","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090247926","display_name":"Veerle Smits","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Smits","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051934471","display_name":"C. Cleybergh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Cleybergh","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. De Wolf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. De Wolf","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054798384","display_name":"Karen Van Baelen","orcid":"https://orcid.org/0000-0002-5700-3574","observed_orcids":["https://orcid.org/0000-0002-5700-3574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Van Baelen","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070724386","display_name":"Lieven J. Stuyver","orcid":"https://orcid.org/0000-0001-7818-9390","observed_orcids":["https://orcid.org/0000-0001-7818-9390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. J. Stuyver","raw_affiliation_strings":["Tibotec-Virco, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco, Beerse, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5016308733"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.3713,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.96092448,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"55","issue":"1","first_page":"321","last_page":"325"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-integrase-inhibitors","display_name":"HIV-1 integrase inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.8899999856948853},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9890000224113464},{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":0.9660000205039978},{"id":"https://openalex.org/keywords/integrase-mutations","display_name":"integrase mutations","score":0.5920000076293945},{"id":"https://openalex.org/keywords/antiviral-susceptibility","display_name":"antiviral susceptibility","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9931684732437134},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9747450351715088},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.9043427109718323},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.8295240998268127},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5885140895843506},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5066829323768616},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4429045021533966},{"id":"https://openalex.org/C2778080818","wikidata":"https://www.wikidata.org/wiki/Q1788422","display_name":"Cross-resistance","level":2,"score":0.41677534580230713},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.36860302090644836},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2746860384941101},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.18950393795967102},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13887321949005127},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09863537549972534}],"mesh":[{"descriptor_ui":"D000068898","descriptor_name":"Raltegravir Potassium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.01733-09","doi":"https://doi.org/10.1128/aac.01733-09","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01733-09","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3019647","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3019647","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:20956600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20956600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3019647","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3019647","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1489859663","https://openalex.org/W1983837630","https://openalex.org/W1998600456","https://openalex.org/W2012752176","https://openalex.org/W2018545343","https://openalex.org/W2025952824","https://openalex.org/W2035999396","https://openalex.org/W2041921162","https://openalex.org/W2066096204","https://openalex.org/W2072883794","https://openalex.org/W2089882643","https://openalex.org/W2114822477","https://openalex.org/W2137646827","https://openalex.org/W2139876724","https://openalex.org/W2146058166","https://openalex.org/W2153000646","https://openalex.org/W2155792409","https://openalex.org/W2412539700"],"related_works":["https://openalex.org/W1995147807","https://openalex.org/W1967390610","https://openalex.org/W2095472461","https://openalex.org/W2086617757","https://openalex.org/W2029289386","https://openalex.org/W2025622116","https://openalex.org/W2104029568","https://openalex.org/W2883402305","https://openalex.org/W2139497502","https://openalex.org/W2327797296"],"abstract_inverted_index":{"The":[0,156],"integrase":[1,42,59,82],"inhibitor":[2],"raltegravir":[3],"(RAL)":[4],"is":[5,20,34,37,162],"currently":[6],"used":[7,73],"for":[8,40],"the":[9,76,104,122,139,142,145],"treatment":[10],"of":[11,24,57,79,138,144],"both":[12],"treatment-na\u00efve":[13],"and":[14,32,50,69,85,117,166],"treatment-experienced":[15],"HIV-1-infected":[16],"patients.":[17],"Elvitegravir":[18],"(EVG)":[19],"in":[21],"late":[22],"phases":[23],"clinical":[25],"development.":[26],"Since":[27],"significant":[28],"cross-resistance":[29,52,77],"between":[30],"RAL":[31],"EVG":[33],"observed,":[35],"there":[36],"a":[38,46],"need":[39],"second-generation":[41,81],"inhibitors":[43],"(INIs)":[44],"with":[45,89,97,103,121],"higher":[47],"genetic":[48],"barrier":[49],"limited":[51],"to":[53,74,110,115,129,159],"RAL/EVG.":[54],"A":[55],"panel":[56],"HIV-1":[58],"recombinants,":[60],"derived":[61],"from":[62,65,152],"plasma":[63],"samples":[64,102],"raltegravir-treated":[66],"patients":[67],"(baseline":[68],"follow-up":[70],"samples),":[71],"were":[72],"study":[75],"profile":[78],"two":[80],"inhibitors,":[83],"MK-2048":[84,116],"compound":[86,118,130,163],"G.":[87,119,131],"Samples":[88,120],"Q148H/R":[90],"mutations":[91],"had":[92,107,125],"elevated":[93],"fold":[94],"change":[95],"values":[96],"all":[98],"compounds":[99],"tested.":[100],"Although":[101],"Y143R/C":[105],"mutation":[106,124],"reduced":[108,127],"susceptibility":[109,128,161],"RAL,":[111],"they":[112],"remained":[113],"susceptible":[114],"N155H":[123],"no":[126],"In":[132],"conclusion,":[133],"our":[134],"results":[135],"allowed":[136],"ranking":[137],"INIs":[140],"on":[141],"basis":[143],"antiviral":[146],"activities":[147],"using":[148],"recombinant":[149],"virus":[150],"stocks":[151],"RAL-treated":[153],"patient":[154],"viruses.":[155],"order":[157],"according":[158],"decreasing":[160],"G,":[164],"MK-2048,":[165],"EVG.":[167]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}